COVID-19 pandemics is a challenge for public health and infectious diseases clinicians especially for the therapeutical approach that is not yet adequately defined. Amid this situation investigational agents are being used including chloroquine. We report here the clinical features and therapeutic course of the first reported patient with confirmed COVID-19 pneumonia that recovered in Colombia after the use of chloroquine and clarithromycin. Successful recovery of COVID-19 pneumonia in a patient from Colombia after receiving chloroquine and clarithromycin.